Diadema Partners »

Voyager Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 574k 3.86

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Voyager Therapeutics

BlackRock
Armistice Capital
Millennium Management
Vestal Point Capital
Vanguard Capital Management
Opaleye Management
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Vanguard Portfolio Management
Morgan Stanley
Erste Asset Management GmbH
Two Sigma Investments
Renaissance Technologies
Diadema Partners

View all funds holding Voyager Therapeutics